C. Tinguely

发表

Immunoglobulin M–Enriched Human Intravenous Immunoglobulin Prevents Complement Activation In Vitro and In Vivo in a Rat Model of Acute Inflammation

M. Daha, R. Rieben, A. Roos, 1999 .

Protocol of a Multicenter International Randomized Controlled Manikin Study on Different Protocols of Cardiopulmonary Resuscitation for laypeople (MANI-CPR)

S. Cornara, A. Somaschini, A. Cortegiani, 2018, BMJ Open.

Mononuclear cells ingest E. coli opsonized by investigational intravenous immunoglobulin preparations in the absence of complement more efficiently than polymorphonuclear phagocytes.

U. Nydegger, M. Schaller, C. Tinguely, 2001, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Quantitation and characterization of anti‐Galα1–3Gal antibodies in sera of 200 healthy persons

R. Rieben, P. Mohacsi, U. Nydegger, 1999, Xenotransplantation.

Immunoglobulin M-enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammation.

M. Daha, R. Rieben, A. Roos, 1999, Blood.

Reverse vertical transmission of hepatitis B virus (HBV) infection from a transfusion-infected newborn to her mother.

J. Allain, D. Candotti, C. Niederhauser, 2012, Journal of hepatology.

Selective Testing of At-Risk Blood Donors for Trypanosoma cruzi and Plasmodium spp. in Switzerland

C. Niederhauser, C. Tinguely, J. Gottschalk, 2016, Transfusion Medicine and Hemotherapy.

Combinations of potent topical steroids, mercury and hydroquinone are common in internationally manufactured skin‐lightening products: a spectroscopic study

L. Wiesner, C. Tinguely, N. Khumalo, 2016, Clinical and experimental dermatology.

Gene usage for naturally occurring antibodies.

U. Nydegger, M. Schaller, C. Tinguely, 2001, Transplantation proceedings.

Efficacy of individual nucleic acid amplification testing in reducing the risk of transfusion‐transmitted hepatitis B virus infection in Switzerland, a low‐endemic region

A. Buser, S. Fontana, G. Canellini, 2010, Transfusion.

Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus?

C. Niederhauser, C. Tinguely, B. Mansouri Taleghani, 2008, Swiss medical weekly.

Fatal outcome of a hepatitis B virus transfusion‐transmitted infection

J. Allain, D. Candotti, W. Wuillemin, 2010, Vox sanguinis.

Current hepatitis E virus seroprevalence in Swiss blood donors and apparent decline from 1997 to 2016

S. Fontana, L. Infanti, Jörg Sigle, 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Evolution of Blood Safety in Switzerland over the Last 25 Years for HIV, HCV, HBV and Treponema pallidum

C. Niederhauser, Michael Vock, C. Tinguely, 2022, Viruses.

A multidimensional cross-sectional analysis of COVID-19 seroprevalence among a police officer cohort: The PoliCOV-19 study

P. Gowland, E. Theel, R. Dijkman, 2021, medRxiv.

Comparison of a New IgG-EIA for the Detection of Anti-Plasmodium Antibodies with Two Currently Used Assays

T. Vollmer, J. Dreier, H. Marti, 2021, Transfusion Medicine and Hemotherapy.

Multicentre Performance Evaluation of the Elecsys Anti-SARS-CoV-2 Immunoassay as an Aid in Determining Previous Exposure to SARS-CoV-2

P. Findeisen, C. Niederhauser, M. Majchrzak, 2021, Infectious Disease and Therapy.

Serosurveillance after a COVID‐19 vaccine campaign in a Swiss police cohort

E. Theel, D. Heg, A. Endimiani, 2022, Immunity, inflammation and disease.

The risk of a second diagnostic window with 4th generation HIV assays: Two cases.

A. Ströhle, C. Niederhauser, C. Tinguely, 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Low-Frequency Blood Group Antigens in Switzerland

M. Krawczak, A. Franke, A. Buser, 2018, Transfusion Medicine and Hemotherapy.

Hepatitis B virus DNA viral load determination in hepatitis B surface antigen–negative Swiss blood donors

S. Fontana, C. Niederhauser, C. Tinguely, 2014, Transfusion.

Differences between synthetic oligosaccharide immunoabsorbents in depletion capacity for xenoreactive anti‐Galα1–3Gal antibodies from human serum

R. Rieben, N. Bovin, B. Gerber, 2001, Xenotransplantation.

Spectrotype analysis and clonal characteristics of human anti‐Gal alpha1–3Gal antibodies

T. Carrel, U. Nydegger, M. Schaller, 2002, Xenotransplantation.

Safe-Testing Algorithm for Individual-Donation Nucleic Acid Testing: 10 Years of Experience in a Low-Prevalence Country

C. Niederhauser, C. Tinguely, P. Gowland, 2019, Transfusion Medicine and Hemotherapy.

Do quantitative levels of antispike‐IgG antibodies aid in predicting protection from SARS‐CoV‐2 infection? Results from a longitudinal study in a police cohort

E. Theel, D. Heg, A. Endimiani, 2023, Journal of medical virology.

A Multidimensional Cross-Sectional Analysis of Coronavirus Disease 2019 Seroprevalence Among a Police Officer Cohort: The PoliCOV-19 Study

E. Theel, R. Dijkman, P. Sendi, 2021, Open forum infectious diseases.

Low-Frequency Blood Group Antigens in Switzerland

M. Krawczak, A. Franke, A. Buser, 2018, Transfusion Medicine and Hemotherapy.